Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

3(27%)

Results Posted

20%(1 trials)

Terminated

1(9%)

Phase Distribution

Ph phase_1

45%

Ph phase_2

Ph phase_4

Ph not_applicable

36%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 1Safety & dosage

5(45.5%)

Phase 2Efficacy & side effects

1(9.1%)

Phase 4Post-market surveillance

1(9.1%)

N/ANon-phased studies

4(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(5)

Terminated(3)

Detailed Status

Completed5

Recruiting3

Withdrawn2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 4

Trials by Phase

Phase 15 (45.5%)

Phase 21 (9.1%)

Phase 41 (9.1%)

N/A4 (36.4%)

Trials by Status

terminated19%

recruiting327%

withdrawn218%

completed545%

Recent Activity

3 active trials

Showing 5 of 11

recruitingphase_1

A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH

NCT05945537

recruitingphase_1

Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

NCT07634770

terminatednot_applicable

Efficacy of Two Enzyme Cocktails in Healthy Adults

NCT06710392

recruitingnot_applicable

Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers

NCT07440147

completedphase_1

A Phase 1 Study of XH-S003 in Healthy Volunteers

NCT05946876

View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials

NCT05945537Phase 1

A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH

Recruiting

NCT07634770Phase 1

Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

Recruiting

NCT06710392Not Applicable

Efficacy of Two Enzyme Cocktails in Healthy Adults

Terminated

NCT07440147Not Applicable

Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers

Recruiting

NCT05946876Phase 1

A Phase 1 Study of XH-S003 in Healthy Volunteers

Completed

NCT05792163Phase 1

A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease

Completed

NCT04389775Phase 1

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

Completed

NCT02223299Not Applicable

Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.

Withdrawn

NCT03788889Phase 4

Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine

Withdrawn

NCT03425578Not Applicable

Glutamate Supplementation in Young Men

Completed

NCT01187901Phase 2

A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients

Completed

All 11 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 11